Dr. Michael Chankwon Park, MD, PhD

Dr. Park practices at M Health Fairview Clinics and Surgery Center - Minneapolis in Minneapolis, Minnesota.

Dr. Park's NPI, 1942427117, was assigned on April 19, 2007. Dr. Park graduated from University of Kansas School of Med (KC/Wich/Sal) in 2002. Dr. Park holds Minnesota license 58653.

Dr. Park's primary practice is M Health Fairview Clinics and Surgery Center - Minneapolis, at 909 Fulton Street Southeast, Minneapolis, MN 55455. The practice phone is (612) 676-5500.

Dr. Park's primary practice is M Health Fairview Clinics and Surgery Center - Minneapolis in Minneapolis, Minnesota. Dr. Park is also affiliated with M Health Fairview University of Minnesota Medical Center. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Park to 3 more group practices and clinics and 3 medical groups, each named with a free account. Dr. Park's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Park practices, 5 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Park's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dmand AI has Dr. Park's licenses on file in 2 states: Minnesota and Kentucky.

Dmand AI lists craniotomy among the conditions Dr. Park treats.

CMS data shows 134 Medicare services from Dr. Park across 6 procedure codes in 2024, for 80 Medicare patients. Medicare paid $57,611 for them.

CMS counts 80 Medicare patients who saw Dr. Park in 2024. The largest group is 65 to 74, with 30 patients. 64% of them have high blood pressure, and 60% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Park's median patient age at 67, with 44% women.

In 2024, Dr. Park wrote 36 Medicare Part D claims for 20 patients. 75% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $148 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Park for performance year 2024, reported as part of a group. Dr. Park accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Park as offering telehealth.

Dmand AI links 30 papers to Dr. Park, published from 2006 to 2025. 2022 was the busiest year, with 5. The most frequent topics are Deep Brain Stimulation, Globus Pallidus and Parkinson Disease. Dr. Park has published most often in J Neurooncol. Dr. Park's most frequent co-authors are Noam Yehezkel Harel, MD, PhD, Jerrold L. Vitek, MD and David Patrick Darrow, MD.

CMS Open Payments shows 96 general payments to Dr. Park from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 42% of the total. Boston Scientific Corporation paid the most, $8,631.

Dmand AI lists 2 awards for Dr. Park, most recently CMS Stage 1 2012 in 2014.

Dr. Park graduated from University of Kansas School of Med (KC/Wich/Sal) in 2002.

Dr. Park is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.